Skip to main content
Top
Published in: Systematic Reviews 1/2012

Open Access 01-12-2012 | Protocol

Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment

Author: Bianca Z Kinnear

Published in: Systematic Reviews | Issue 1/2012

Login to get access

Abstract

Background

Spasticity of muscles is a common consequence of central nervous system impairment. Traditionally, neurological rehabilitation for spasticity has involved occupational and physical therapy; however, increasingly Botulinum toxin–A injections may be provided. Injection effects are temporary. Consequently, understanding the effect of adjunct physical therapies will help inform multimodal rehabilitation decisions. Presently, these effects are not known. This systematic review will identify and summarize evidence on physical therapies used after Botulinum toxin-A injection to improve motor function in adults with neurological impairments.

Method

Systematic searching of seven electronic databases will occur to identify relevant randomized trials. Available trial data will be extracted into a list of pre-defined primary outcomes, including range of movement, spasticity and functional limb use. Pre-defined secondary outcomes will also be reviewed where trials have these data available for reporting. Effects will be expressed as mean differences or standardized mean differences with 95% confidence intervals (CI). Where possible, comparable results will be meta-analyzed, and a summary of the available pool of evidence produced.
All randomized controlled trials will be rated using the PEDro methodological quality scale. Where possible, study data will be meta-analyzed using RevMan 5 Software. The protocol was registered in PROSPERO international prosepective register of systematic reviews (PROSPERO 2011:CRD42011001491).

Discussion

Review results will be the most comprehensive answer available to the following question: Are physical therapies clinically effective after Botulinum toxin-A injections in adults with neurological spasticity? Results will inform healthcare providers and managers who determine who gets access to and provision of Botulinum toxin-A injection and whether this is done with or without physical therapies. Results will inform the clinicians who conduct physical therapy following injection. This protocol provides readers with the scope and depth of a search that will ultimately answer a complex and pressing treatment question. The variability of current practice and high level of expense associated with multimodal rehabilitation means review results will be more useful and less contestable if the protocol is revealed in full through advance publication.
Literature
1.
go back to reference Lance JW: In Spasticity: Disordered Motor Control. Symposium synopsis. Edited by: Feldman RG, Young RR, Koella WP. 1980, Miami: Symposia Specialists, 485-494. Lance JW: In Spasticity: Disordered Motor Control. Symposium synopsis. Edited by: Feldman RG, Young RR, Koella WP. 1980, Miami: Symposia Specialists, 485-494.
2.
go back to reference Sheean G, Lannin N, Turner-Stokes L, Rawicki B, Snow BJ, Cerebral Palsy Institute: Botulinum toxin assessment, intervention and after care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010, 17: 74-93.CrossRefPubMed Sheean G, Lannin N, Turner-Stokes L, Rawicki B, Snow BJ, Cerebral Palsy Institute: Botulinum toxin assessment, intervention and after care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010, 17: 74-93.CrossRefPubMed
3.
go back to reference Yelnik AP, Colle FM, Bonan IV, Vicaut E: Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007, 78: 845-848. 10.1136/jnnp.2006.103341.CrossRefPubMed Yelnik AP, Colle FM, Bonan IV, Vicaut E: Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007, 78: 845-848. 10.1136/jnnp.2006.103341.CrossRefPubMed
4.
go back to reference Cardoso E, Rodrigues B, Lucena R, de Reis Oliveira I, Pedreira G, Melo A: Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta- analysis. Arq Neuropsiquiatr. 2005, 63: 30-33. 10.1590/S0004-282X2005000100006.CrossRefPubMed Cardoso E, Rodrigues B, Lucena R, de Reis Oliveira I, Pedreira G, Melo A: Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta- analysis. Arq Neuropsiquiatr. 2005, 63: 30-33. 10.1590/S0004-282X2005000100006.CrossRefPubMed
5.
go back to reference Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM: Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry. 2000, 69: 217-221. 10.1136/jnnp.69.2.217.CrossRefPubMedPubMedCentral Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM: Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry. 2000, 69: 217-221. 10.1136/jnnp.69.2.217.CrossRefPubMedPubMedCentral
6.
go back to reference Chin TY, Graham HK: Botulinum toxin A in the management of upper limb spasticity in cerebral palsy. Hand Clin. 2005, 19: 591-600.CrossRef Chin TY, Graham HK: Botulinum toxin A in the management of upper limb spasticity in cerebral palsy. Hand Clin. 2005, 19: 591-600.CrossRef
8.
go back to reference Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology: Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008, 70: 1691-1698. 10.1212/01.wnl.0000311391.00944.c4.CrossRefPubMed Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology: Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008, 70: 1691-1698. 10.1212/01.wnl.0000311391.00944.c4.CrossRefPubMed
9.
go back to reference Hagedorn R: Foundations for Practice in Occupational Therapy. 2009, New York: Churchill Livingstone, 2 Hagedorn R: Foundations for Practice in Occupational Therapy. 2009, New York: Churchill Livingstone, 2
10.
go back to reference Hesse S, Brandi-Hesse B, Bardeleben A, Werner C, Funk M: Botulinum toxin A treatment of adult upper and lower limb spasticity. Drugs Aging. 2001, 18: 255-262. 10.2165/00002512-200118040-00003.CrossRefPubMed Hesse S, Brandi-Hesse B, Bardeleben A, Werner C, Funk M: Botulinum toxin A treatment of adult upper and lower limb spasticity. Drugs Aging. 2001, 18: 255-262. 10.2165/00002512-200118040-00003.CrossRefPubMed
11.
go back to reference Kinnear B, Lannin N, Cusick A: The promise and potential of botulinum toxin-A: national survey of therapy practices. Int J Stroke. 2011, 6 (Suppl. 1): 17- Kinnear B, Lannin N, Cusick A: The promise and potential of botulinum toxin-A: national survey of therapy practices. Int J Stroke. 2011, 6 (Suppl. 1): 17-
12.
go back to reference Hoare B, Imms C: Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for Occupational Therapists. Am J Occup Ther. 2004, 58: 389-397. 10.5014/ajot.58.4.389.CrossRefPubMed Hoare B, Imms C: Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for Occupational Therapists. Am J Occup Ther. 2004, 58: 389-397. 10.5014/ajot.58.4.389.CrossRefPubMed
13.
go back to reference Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL: Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair. 2010, 24: 34-41. 10.1177/1545968309341060.CrossRefPubMed Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL: Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair. 2010, 24: 34-41. 10.1177/1545968309341060.CrossRefPubMed
14.
go back to reference Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM: Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008, 39: 2803-2808. 10.1161/STROKEAHA.108.516153.CrossRefPubMed Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM: Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008, 39: 2803-2808. 10.1161/STROKEAHA.108.516153.CrossRefPubMed
15.
go back to reference Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, Ofluoqlu D: The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Top Stroke Rehabil. 2010, 17: 318-322. 10.1310/tsr1704-318.CrossRefPubMed Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, Ofluoqlu D: The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Top Stroke Rehabil. 2010, 17: 318-322. 10.1310/tsr1704-318.CrossRefPubMed
16.
go back to reference The Nordic Cochrane Centre: Review Manager (RevMan). 5.0. The Cochrane Collaboration. 2008, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration The Nordic Cochrane Centre: Review Manager (RevMan). 5.0. The Cochrane Collaboration. 2008, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration
17.
go back to reference Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M: Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003, 83: 713-715.PubMed Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M: Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003, 83: 713-715.PubMed
18.
go back to reference Harvey L, Herbert R, Crosbie J: Does stretching induce lasting increases in joint ROM? A systematic review. Physiother Res Int. 2002, 7: 1-13. 10.1002/pri.236.CrossRefPubMed Harvey L, Herbert R, Crosbie J: Does stretching induce lasting increases in joint ROM? A systematic review. Physiother Res Int. 2002, 7: 1-13. 10.1002/pri.236.CrossRefPubMed
19.
go back to reference Schultz KF, Chalmers I, Hayes RJ, Aitman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273: 408-412. 10.1001/jama.1995.03520290060030.CrossRef Schultz KF, Chalmers I, Hayes RJ, Aitman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273: 408-412. 10.1001/jama.1995.03520290060030.CrossRef
20.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000, 283: 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000, 283: 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed
21.
go back to reference Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration, Available fromwww.cochrane-handbook.org, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration, Available fromwww.​cochrane-handbook.​org,
22.
go back to reference Wissel J, Ward AB, Ertzgaard P, Bensmail B, Hecht MJ, Lejeune TM, Schnider P: European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009, 41: 13-25. 10.2340/16501977-0303.CrossRefPubMed Wissel J, Ward AB, Ertzgaard P, Bensmail B, Hecht MJ, Lejeune TM, Schnider P: European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009, 41: 13-25. 10.2340/16501977-0303.CrossRefPubMed
23.
go back to reference Royal College of Physicians London: National Guidelines Spasticity in Adults: Management Using Botlulinum Toxin. 2009, Aberystwyth: Cambrian Printers Ltd Royal College of Physicians London: National Guidelines Spasticity in Adults: Management Using Botlulinum Toxin. 2009, Aberystwyth: Cambrian Printers Ltd
Metadata
Title
Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
Author
Bianca Z Kinnear
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2012
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/2046-4053-1-29

Other articles of this Issue 1/2012

Systematic Reviews 1/2012 Go to the issue